Technology That Puts Time Back on Patients' Side

Local labs gain access to high-quality molecular tests, enabling them to develop next-generation sequencing (NGS) assays for somatic testing of adult solid tumors. Avitia’s custom service model ensures these solutions work seamlessly for labs at any level of expertise.

Generate NGS-based gene panels to rapidly detect DNA and RNA tumor mutations, including mutation detection across a full range of clinical diagnostic samples collected in routine pathology workflows. This provides actionable information for high-quality, robust, and cost-effective clinical testing. Avitia’s assays deliver a complete, end-to-end solution for laboratories, featuring efficient workflows and a rapid 3-5 day turnaround time.

Avitia’s sample-to-report workflow leverages cloud-based analytics while prioritizing personal health information security. By seamlessly integrating with internal LIMS or EMR systems, Avitia minimizes manual data entry and maintains PHI data security —  ensuring patient data never leaves the local server.

Avitia’s Partners Network drives precision medicine advancements while benefiting from collective insights across diverse patient cohorts, jurisdictions, and therapeutic indications.